1278P SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I study
医学
双功能
队列
肿瘤科
融合蛋白
内科学
癌症研究
重组DNA
生物化学
基因
催化作用
化学
作者
J. Feng,J. Chen,K. Li,X. Li,Min Xiao,B. Li,Lizhu Lin,Yong Fang,Yang Sun,Bo Zhu,Q. Wang,L. Wang,Jianjun Zou,P. Liu